Insulin is capable of increasing intracellular magnesium, although very little is known about the effect of insulin on the biologically active fraction of magnesium, i.e. the ionized quota (Mg 2C i ), its interactions with glucose, and the cellular mechanisms involved in these processes. We studied the interactions of the effects of insulin and glucose on intracellular ionized magnesium in human lymphocytes. Mg 2C i was measured using a fluorimetric method and the Mg 2C -sensitive dye, furaptra. We found that insulin significantly increases the Mg 2C i (without insulin 227G14 mM, with 10 mU/ml, insulin 301G30 mM, P!0$0001, nZ12) in a dose-dependent manner in all three glucose concentrations tested (5, 7 and 15 mmol/l). The half-maximal effect of insulin was approximately 0$8 mU/ml. Glucose and insulin showed opposite effects in their ability to modify Mg 
Introduction
A potential role of magnesium deficiency in the pathogenesis of type 2 diabetes mellitus has been recently proposed based on epidemiological, nutritional, and experimental data. In fact, large observational studies have described an association between low serum magnesium levels and type 2 diabetes (Ma et al. 1995) . Accordingly, magnesium supplementation might be useful in the prevention and treatment of diabetes (Schnack et al. 1992) . In vitro studies have shown an effect of magnesium on insulin secretion by the pancreas and on the mechanism of peripheral insulin resistance (Hwang et al. 1993) . Our group has shown that intracellular ionized magnesium (Mg 2C i ) concentrations are decreased in patients with insulin resistance syndrome (Delva et al. 1996 (Delva et al. , 1998a and that peripheral insulin resistance is related to Mg 2C i levels (Delva et al. 1998b ). Furthermore, we have shown in vitro that high extracellular glucose at concentrations compatible with those found in diabetes can reduce the concentration of Mg 2C i (Delva et al. 2002) . Insulin has been shown to increase the Mg 2C i concentration in human erythrocytes (Barbagallo et al. 1993 (Barbagallo et al. , 1997 , platelets (Hwang et al. 1993) , and the total intracellular magnesium in rat ventricular myocytes (Romani et al. 2000) , and prevents Mg 2C extrusion induced by isoproterenol (Romani et al. 2000) . Nonetheless, very little is known about the effect of insulin on the biologically active fraction of magnesium, i.e. the ionized quota, in nucleated human-derived cells, its interactions with glucose, and the cellular mechanisms involved. We have studied the interactions between insulin and glucose on Mg 2C i in human lymphocytes in order to shed light on the cellular mechanisms involved in these processes.
Material and Methods

Reagents
The Ficoll-Histopaque reagent was obtained from Sigma Chemical, as were the RPMI 1640, BSA free fatty acids, and all the sugars utilized. MgCl 2 , lanthanum oxide (ultrapure grade), wortmannin, vandate and insulin were obtained from Sigma. Furaptra-acetoxymethyl ester and fura-2 acetoxymethyl ester were provided by Molecular Probes Inc. (Eugene, OR, USA).
Preparations of human lymphocytes
All studies were performed on human lymphocytes obtained from the local blood bank from healthy blood donors. Consent was obtained from the subjects after the nature of the procedure was explained. Peripheral blood lymphocytes were isolated as follows: total blood was diluted with RPMI 1640 medium (HEPES modification, glucose-free and supplemented with MgSO 4 to reach the concentration of 0$8 mM) and layered carefully onto Histopaque 1077 and then centrifuged for 30 min at 400 g. The layer of lymphocytes was carefully aspirated and washed twice in RPMI 1640 for 10 min at 150 g. The cells thus obtained were allowed to sediment for 30 min in culture flasks. The supernatant was then transferred into tubes and centrifuged, and the lymphocytes thus obtained were resuspended in the same medium. The percentage of lymphocytes always exceeded 95% and the vitality assessed as Trypan Blue exclusion was always higher than 97%.
Measurement of free intralymphocyte magnesium
We used the method previously described by Delva et al. (1996) . Lymphocytes were counted by means of a Coulter Counter (Coulter Electronics Ltd, Dunstable, Beds, UK). The cells were washed three times with RPMI 1640 and then three separate aliquots of lymphocytes (6!10 6 cells each) were suspended in RPMI 1640 with insulin (or the relevant substance) and three aliquots (6!10 6 cells each) without insulin (control cells). In some experiments, when the concentration of extracellular Mg 2C was varied, RPMI 1640 was substituted with Bulher solution containing (in mM) NaCl 145, KCl 5, Na 2 HPO 4 0$5, HEPES 10, CaCl 2 1, MgSO 4 0-3. All the aliquots had BSA 0$1% (v/v) and the cell permeant furaptra-acetoxymethyl ester 10 mM added to them for 1 h at 37 8C. After centrifugation, the cells were washed twice in the same medium to remove extracellular dye and resuspended in the same medium at room temperature for 45 min for complete deesterification of the dye. For the measurement of intracellular Mg 2C , the buffer utilized contained (in mM) 140 NaCl, 5 KCl, 1$8 CaCl 2 , 0$8 MgSO 4 , and 15 HEPES with or without insulin for the insulin-incubated aliquots and without insulin for the insulin-free aliquots (pH 7$4 at 31 8C). After washing off the 1640 medium, the cells were added to the above prewarmed medium (31 8C) just before the fluorimetric measurements were performed. Fluorescence emission at 510 nm (slit width 10 nm) was measured with alternate excitation at 335 and 370 nm (slit width 10 nm) within a thermostatically controlled cuvette holder (31 8C) in a Hitachi F-2000 fluorescence spectrophotometer. Autofluorescence contributed to less than 1% of the total fluorescence values. One centimeter quartz cuvettes were used for all experiments. After reading the initial fluorescence emission resulting from excitation at 335 and 370 nm, 5 mM EDTA and 5 mM EGTA were added to the cuvette. Since extracellular Mg 2C and Ca 2C were chelated in the medium, a rapid-step change in fluorescence at both wavelengths occurred due to dye leaking from inside the cells. The immediate (!10 s) change in fluorescence intensities at both wavelengths after the addition of EDTA and EGTA was considered in order to calculate the free resting intracellular Mg
2C
. Triton X-100 was then added to a final concentration of 0$1% (v/v) to lyse the cells, and since the cells were in a medium containing EDTA and EGTA, it was possible to determine the minimum fluorescence ratio, R min . Subsequently, MgSO 4 (100 mM) was added to obtain the maximum fluorescence ratio, R max . Intracellular-free Mg was measured in triplicate and was calculated according to (Raju et al. 1989) . The K d of intracellularly generated furaptra for Mg 2C in our experimental condition was calculated to be 2$1 mM as previously described (Delva et al. 2004 ).
Measurement of free intralymphocyte magnesium in the cytosol and intracellular organelles
We performed an indirect estimate of Mg 2C i in the cytosol and intracellular organelles of lymphocytes, both in the presence of insulin and in its absence, by differential permeabilization of the cells (Delva et al. 2004) . We used the procedure described above to measure lymphocyte steady-state Mg 2C i further by adding, after the addition of EGTA/EDTA mixture, digitonin (25 mg/l) in order to permeabilize the cell plasma membrane. In this condition, the cytosolic free magnesium is expected to leave the cell following its outwardly directed gradient and all the fluorescence measured is derived from intracellular organelles. Then, we indirectly calculated the cytosolic free magnesium concentration by subtracting the magnesiumfree concentration in the organelles from the lymphocyte steady-state Mg 2C i concentration of the cell.
Measurement of free intralymphocyte calcium
The intracellular Ca 2C of lymphocytes was measured using fura-2 as previously described by Delva et al. (1996) . Six aliquots of cells (6!10 6 each) were incubated following the same strategy used for Mg 2C i determinations (with or without insulin) with 5 mM fura-2-acetoxymethyl ester for 1 h at 37 8C, and then washed twice and left for 45 min at room temperature before any measurements were made. For fluorimetric measurements, the same buffer used for Mg 2C i assay was utilized and the cells were added to a pre-warmed medium with a technique similar to that used for the Mg 2C i assay. EGTA (10 mM) was added to chelate Ca 2C in the medium, thus producing a desaturation of fura-2, which leaked from inside the cells, and giving a rapid-step change in fluorescence emission at 510 nm with excitation set at both 340 and 380 nm wavelengths. This provided the ratio values for the intracellular Ca 2C resting calculation (Grynkiewicz et al. 1985 ) using a K d value for 175 nM Ca 2C /fura-2 complex as previously calculated in our experimental conditions (Delva et al. 2004 ).
The intra-and inter-assay variability (coefficient of variation) determinations were 5$8 and 3$9% for ionized Mg 2C i and 4$6 and 12$7% for ionized Ca 2C i determinations.
Measurement of total intralymphocyte magnesium
We utilized the method described by Elin and Hosseine (1985) with some modifications as previously described (Delva et al. 2004 ).
Measurement of intralymphocyte ATP
ATP content of human lymphocytes was measured as described by Nieminen et al. (1990) with minor variations (Delva et al. 2004 ).
Statistical analysis
Results are expressed as meansGS.D. if no other method is specified. Comparison between groups was performed using Student's t-test and considered statistically significant when the probability of the null hypothesis was below at least 5%. Confidence limits for differences in means were also provided. For multiple comparisons, a one-way ANOVA test with Bonferroni's correction for multiple comparisons was used.
Results
Effect of insulin on the intralymphocyte ionized magnesium concentration
The steady-state Mg 2C i in the incubation media without insulin was 227G14 mM (nZ12). Incubation of lymphocytes for 2$5 h with 10 mU/ml insulin significantly increased this value (301G30 mM, P!0$0001, 95% confidence interval: 49-96 mM, nZ12) ( by 10 mU/ml insulin is measurable after 30 min, reaching a maximal effect after 120 min. The in vitro effects of insulin comparisons to IGF-1 and insulin-mimetic stimuli, glucose analogs, inhibitors of insulin signaling and inhibitors of glucose metabolism are summarized in Table 1 . The interrelationships between the in vitro effects of insulin and inhibitors or regulators of transmembrane Mg 2C fluxes in human lymphocytes are summarized in Table 2 .
Effects of differential permeabilization of lymphocytes on insulin-induced Mg 2C i increases
In the absence of insulin, the lymphocyte whole-cell Mg were 126G23, 20G7, 106G23 mM, respectively (nZ5). In the presence of 10 mU/ml insulin, these values were 177G26, 29G4, and medium) with insulin and wortmannin (0$1 mmol/l) 6 165G15 P!0$01 vs control cells without insulin 17-59 1,2-Dioctanoyl-sn-glycerol (100 mmol/l) without insulin 4 305G38 P!0$01 vs control cells without insulin 40-87 1,2-Dioctanoyl-sn-glycerol (100 mmol/l) with insulin 4 335G36 P!0$001 vs control cells without insulin 50-97 Control cells (Na C medium) with vanadate (50 mmol/l) 3 78G18 Control cells (Na C medium) with vanadate (1 mmol/l) 6 135G20 P!0$003 50-120 Control cells (Na C medium) with insulin growth factor 1 (20 nmol/l) 6 230G50 Control cells (Na C medium) with 2-DOG (100 mmol/l) 6 570G65 P!0$0001 210-400 Control cells (Na C medium) with iodoacetic acid (300 mmol/l) 6 530G60 P!0$0001 100-270
All measurements were performed after 2$5 h; insulin when indicated is 10 mU/ml. MeanGS.D. values of 3-12 independent experiments were provided; CI: 95% confidence limits. 2-DOG: 2-deoxy-D-glucose. Under our experimental conditions, the incubation of lymphocytes for 2$5 h with 10 mU/ml of insulin did not produce any statistically significant modifications in the concentration of ATP i , (control medium, 5$31G0$73 mM; insulin-treated, 5$78G0$85 mM, nZ6).
Total intracellular magnesium in lymphocytes incubated in the medium without insulin was 19G2 mM (nZ12). Incubation of lymphocytes for 2$5 h with 10 mU/ml of insulin did not significantly modify this value (glucosetreated, 18$7G1$5 mM, nZ12).
As far as ionized intracellular calcium is concerned, incubation of lymphocytes for 2$5 h with 100 mU/ml of insulin did not modify the concentration of Ca 2C i in lymphocytes (without insulin, 60G11 nM, with insulin 65G12, nZ8).
Discussion
Incubation of human lymphocytes with insulin at concentrations that mimic both physiological and pathological situations results in a significant increase in the Mg 2C i concentration, confirming data obtained from anucleated human-derived cells such as erythrocytes (Barbagallo et al. 1993 (Barbagallo et al. , 1997 and platelets (Hwang et al. 1993) . However, in these previous studies, the interrelationships between intracellular magnesium, glucose and insulin were not investigated. Paolisso et al. (1986) were the first to show in human erythrocytes that insulin in vitro increases erythrocyte magnesium, an effect that is entirely abolished by ouabain. The same authors then showed that the insulin-induced magnesium increase in erythrocytes is different in patients with type 2 diabetes (Paolisso et al. 1988) or obese subjects (Paolisso et al. 1990 ) compared with healthy subjects. Dominguez et al. (1998) confirmed in human erythrocytes that insulin is capable of increasing intracellular free magnesium in a dose-and time-dependent manner (Barbagallo et al. 1993) and that IGF-1 has a similar effect. Hwang et al. (1993) confirmed these results in a different cell model, namely the human platelet, and showed that insulin had a dose-and time-dependent effect on the increase of [Mg 2C ] i and suggested that insulin can translocate Mg 2C from the extracellular space. Takaya et al. (1998) confirmed and extended the results on human platelets showing that IGF-1 produces the same increases in Mg 2C i as insulin. The involvement of Na C -Mg 2C exchanger was judged as improbable and insulin/IGF-1 translocates Mg 2C from the extracellular space.
To our knowledge, only Hua et al. (1995) have studied the in vitro effects of insulin on human resting lymphocytes and confirmed the results obtained from erythrocytes and platelets by demonstrating that insulin in vitro can increase Mg 2C i in human resting lymphocytes. The results obtained from the present work are in agreement with the above results obtained from a different cell model utilizing different methodological approaches. As far as we know, the only study performed in insulin-target cells was performed in rat hepatocytes by Keenan et al. (1996) , who demonstrated that insulin is able to block the Mg 2C efflux from perfused rat livers stimulated by isoproterenol.
We have previously studied the in vitro effect of glucose alone on Mg 2C i in human lymphocytes and found that in the absence of insulin, glucose is capable of decreasing the Mg 2C i in a dose-dependent and stereospecific manner (Delva et al. 2002) . The glucose-induced increase in intracellular ATP, binding a greater amount of Mg 2C i and forming MgATP, seems to be the most likely cause for the glucose-induced decrease in ionized magnesium (Delva et al. 2002) .
In the present paper, we studied the in vitro effects of insulin, both alone or in combination with glucose, on lymphocyte Mg 2C i . The latter situation, i.e. the interaction between insulin, glucose, and Mg 2C i , which obviously tries to mimic the physiological situation, is complex. As shown in Fig. 1A , insulin is capable of significantly increasing the Mg 2C i in all glucose concentrations tested, which were intended to mimic conditions of overt hyperglycemia (15 mmol/l), hyperglycemia (10 mmol/l) and fasting (5 mmol/l). From a kinetic point of view, the three dose-response curves are sigmoidal with approximately the same EC 50 . The time courses of the insulin-induced increase in Mg 2C i (Fig. 1B) and glucose-induced decreases in Mg 2C i (Delva et al. 2002) are superimposable as far as the timing of initial and maximal effect are concerned. The effect of both insulin and glucose on intralymphocyte-ionized magnesium does not begin immediately, but takes place after about 30 min.
Regarding the mechanisms involved in the insulinmediated increase of Mg 2C i , the lack of effects of inhibitors of the membrane Na C -K C pump (ouabain) and membrane Na
i is at odds with the possibility that these membrane transport systems are involved. The substitution of extracellular sodium with choline, which blocks the membrane Na C -Mg 2C exchanger, abolishes the insulin-mediated increase of Mg 2C i . However, since the method for blocking the Na C -Mg 2C exchanger increases cytosolic Mg 2C to a very high level and may even be toxic, we used two well-known inhibitors of the Na C -Mg 2C exchanger: imipramine and quinidine (Feray and Garay 1986) . In the presence of either inhibitor, no increase in Mg was induced by insulin. This is in favor of the hypothesis that insulin is capable of increasing the Mg 2C i by inhibiting this membrane transport.
In contrast with previous data (Romani et al. 2000) , insulin is capable of increasing the Mg 2C i even in the absence of extracellular glucose or magnesium. This latter fact would exclude that an Ca increases progressively both in the absence and presence of insulin. In fact, the two curves are parallel, which, together with the lack of modification of total intracellular magnesium in the presence of insulin, suggests that the insulin-induced increase in Mg 2C i
is not due to increases in passive permeability. Data obtained with differential membrane permeabilization do not seem to localize the insulinmediated increase of Mg 2C i either in the cytosol or in cellular organelles.
In order to better understand the mechanism of the insulin effects on Mg 2C i , we evaluated molecules characterized by an insulin-mimicking action such as IGF-1 and vanadate. Dominguez et al. (1998) were the first to test in vitro the effects of IGF-1 on intracellular magnesium. IGF-1 is capable of increasing Mg 2C i in erythrocytes from normotensive and hypertensive subjects. The results in which no effects of IGF-1 could be detected on lymphocyte Mg 2C i are difficult to compare to those obtained by Dominguez et al. (1998) because different cell models and analytical methods were used. Barbagallo et al. (2001) have been the only investigators to assess the effect of vanadate on intracellular magnesium compared to the effects of insulin. In the experimental conditions utilized (in the erythrocyte measuring with nuclear magnetic resonance), vandate increased Mg 2C i in a manner that was comparable to insulin at a concentration of 50 mmol/l, while at a concentration of 1 mmol/l, it had the opposite effect and produced a decrease. We tested two concentrations of vanadate on lymphocytes. At high concentrations (1 mmol/l), it decreased Mg 2C i , while at 50 mmol/l, vanadate did not show any effect on lymphocyte magnesium. The discrepancy of the effects of vanadate on Mg 2C i in lymphocytes with respect to erythrocytes is difficult to reconcile with the current cellular model and the different methods of measurement. However, if this were the case, our results would also be different for insulin, which is in agreement with published studies. Our data suggests that in lymphocytes, vanadate does not mimic insulin action. The decrease in Mg 2C i seen at high concentrations may be attributable to the toxicity of vanadate on various membrane transport systems (Domingo 2002) .
PI 3-kinase is known to be a part of the signaling pathways for Na C transporters. In adipose tissue, PI 3-kinase has been shown to be activated by insulin and to mediate the effect of insulin on glucose transport. To examine the role of PI 3-kinase on insulin-induced Mg 2C i increase, we measured ionized magnesium in lymphocytes incubated with insulin in the presence and absence of wortmannin (WT), an established inhibitor of PI 3-kinase. Incubation of lymphocytes with 100 mU/ml insulin and 0$1 mmol/l WT completely blocked the insulin-stimulated Mg 2C i increase, suggesting yet another role for the PI 3-kinase pathway in insulin-mediated cellular events. Ferreira et al. (2003) Table 1 , and we propose that it is likely to be due to a decrease in intracellular ATP and the consequent increase in free, unbound magnesium. The massive increase of ionized intracellular magnesium produced by both these substances prevents the measurement of any additional effects of insulin.
Even though the calcium determination was not the main aim of the study, intralymphocyte-free calcium was also measured, mainly to exclude substantial intracellular calcium increase that may theoretically affect magnesium determinations (Hurley et al. 1992 ). Insulin did not alter the Ca 2C i , thus confirming the results obtained in vitro in other cell models (Thomas et al. 1985) .
In conclusion, we have shown for the first time in human nucleated cells the ability of insulin to modify in vitro the concentration of Mg 2C i through a mechanism based on activation of a Na C -Mg 2C membrane transport system, possibly through the mediation of PI 3-kinase and PKC activation. Taking into account the relationship between insulin and glucose plasma levels and their opposite effects on Mg 2C i , this may represent the two limbs of a biphasic regulatory system of Mg 2C i in both physiological and pathological conditions. An increase of insulin in response to eating, and therefore before an increase in plasma glucose levels, can be hypothesized, increasing Mg 2C i and augmenting the activity of enzymes involved in glucose metabolism to bring about conditions that are more appropriate for metabolism and production of energy. Moreover, this effect would be produced as a final result of the increased enzymatic velocity and decrease in the extracellular concentration of glucose to reestablish glucose homeostasis. The decrease in extracellular glucose thus obtained would bring about a decrease in insulinemia that would precede a decrease in Mg 2C i , with reestablishment of cellular magnesium. In type 1 or 2 diabetes mellitus, the elevated plasma glucose concentrations in the absence of insulin or in situations of peripheral resistance to its actions would produce a prevailing effect, decreasing the inhibition of Mg 2C i . This would lead to a slowing of glucose degradation and would negatively influence magnesium-dependent enzymatic reactions. In addition, it would explain the frequent observation of reduced intracellular magnesium concentrations in patients with diabetes mellitus (Paolisso et al. 1988) .
It is clear that this mechanism, which has been shown in lymphocytes, cannot easily be extrapolated to other cellular models that are much more important in the physiopathology of glucose metabolism, both in physiological conditions and in diabetes mellitus. Despite this, a direct correlation has been described between the concentration of magnesium in lymphocytes and that in striated muscular tissue (Dyckner and Wester 1985) . It must also be remembered that some authors have shown that there is an alteration of pyruvate dehydrogenase (Curto et al. 1997) in the lymphocytes of patients with type 2 diabetes mellitus, which is in agreement with studies carried out in adipocytes (Mandarino et al. 1986) and in skeletal muscle (Kelley et al. 1992 ) of patients with type 2 diabetes mellitus. Finally, several investigators have described the presence of GLUT3 in human lymphocytes (Estrada et al. 1994) , which is a transporter in some cell types that have been shown to be insulin sensitive (Bilan et al. 1992) . Estrada et al. (1994) have also demonstrated that in contrast to monocytes, lymphocytes show a significant increase in the expression of GLUT3 in patients with insulin-dependent diabetes mellitus with respect to healthy control subjects.
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